Reliant Omacor Launch Funded Through IPO; Launch Set For Late 2005
Executive Summary
Reliant Pharmaceuticals will raise cash through an initial public offering to pay for a sales force expansion for the launch of the triglyercide therapy Omacor
You may also be interested in...
Omacor medication errors
The Institute of Safe Medication Practices is recommending that the name of Reliant's hypertriglyceridemia therapy Omacor (omega-3-acid ethyl esters) be changed due to similarity with Xanodyne's antifibrinolytic agent Amicar (aminocaproic acid). "Prescriptions for Omacor have just begun to arrive in pharmacies, but we've already heard name-related safety issues. A pharmacist reported an error in which a telephone order of Omacor 1 g B.I.D. was misheard as Amicar 1 g B.I.D.," the Nov. 3 issue of ISMP's Medication Safety Alert! says. Reliant launched Omacor in October, following approval in November 2004 (1"The Pink Sheet" June 6, 2005, p. 9)...
Omacor medication errors
The Institute of Safe Medication Practices is recommending that the name of Reliant's hypertriglyceridemia therapy Omacor (omega-3-acid ethyl esters) be changed due to similarity with Xanodyne's antifibrinolytic agent Amicar (aminocaproic acid). "Prescriptions for Omacor have just begun to arrive in pharmacies, but we've already heard name-related safety issues. A pharmacist reported an error in which a telephone order of Omacor 1 g B.I.D. was misheard as Amicar 1 g B.I.D.," the Nov. 3 issue of ISMP's Medication Safety Alert! says. Reliant launched Omacor in October, following approval in November 2004 (1"The Pink Sheet" June 6, 2005, p. 9)...
Reliant Will Add Antara, Omacor To Cardiovascular Product Line In 2005
Reliant will launch two recently-approved cardiovascular products, Antara and Omacor, in 2005